PPT-SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED

1 ViiV Healthcare Brentford UK 2 Centre Hospitalier de Tourcoing Tourcoing France 3 Holdsworth House Medical Brisbane Queensland Australia 4 CHU SaintPierre Brussels Belgium 5. Use of licensed combination vaccines is generally preferred to separate injections of the ir equivalent component vaccines When administering combination vaccines the minimum age for administration is the oldest age f or any of the individual compon What Next?. CTCA Conference 2012. John Jereb, FSEB, DTBE, CDC. Special thanks to Christine Ho,. Elsa Villarino, and Andrey Borisov. The findings and conclusions in this presentation are those of the presenter and do not necessarily represent the views of CDC. 2016. Youngju Pak, PhD.. Biostatistician. ypak@labiomed.org. Session . 2. Understanding Equivalence and . Noninferiority. testing. Testing Inequality . v.s. . Equality. Testing Inequality. Ha: | mean(treatment ) - mean (control ) | ≠ 0. TIPS TO GAIN CONTROL. HTN Burden of Disease. Importance of Appropriate HTN Treatment. Case Study: Michael. Case Study: Michael (cont). Potential Reasons for Uncontrolled BP in Michael. Case Study: Michael (cont). (Gk.) : “things that pertain to Aphrodite”. . venerea. (Lat.) : “things that pertain to Venus”. Sexual Identity and Power Relations. SUPERIOR. INFERIOR. ACTIVE. PASSIVE. PENETRATOR. PENETRATED. AIDS Clinical Trials Group A5349. Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: . A randomized, open-label, controlled . phase 3 clinical trial. . Payam Nahid, MD, MPH. Doravirine. /Lamivudine/TDF is Non-Inferior to . Efavirenz. /. Emtricitabine. /TDF in Treatment-Naïve Adults With HIV-1 Infection: Week 48 Results of the Phase 3 DRIVE-AHEAD Study. Kathleen E Squires. Program Goals. Complementary Mechanism of Action . . DPP-4 Inhibitors SGLT2 Inhibitors . Clinical Pearls. Fixed-Dose Combination Therapies. Using Fixed-Dose Combination Therapies to Achieve HbA. 1c. in . Bangkok . MSM . (HPTN . 067/ADAPT Study). Tareerat . Chemnasiri, . Anchalee . Varangrat, . K. Rivet . Amico. , . Supaporn. . Chaikummao. , . Anupong. . Chitwarakorn. , . Bonnie J. . Dye, . Robert M. . New pricing agreement will speed up access to generic, dolutegravir (DTG)-based fixed dose combinations (FDCs) . HIV positive people in low- and middle-income countries including South Africa can be treated for around R900 (US $75 a year) . P.L. . Toutain. VMAS . symposium/workshop. Uppsala 13 December 2017 . Veterinary Committee on Antimicrobial. Susceptibility Testing (VetCAST). 1-What is PK/PD approach . for . antibiotics?. What is . to . Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib, and . Low. -Dose Dexamethasone in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma. Richardson PG et . tenofovir. . alafenamide. (TAF) in virologically suppressed (VS) persons. Kayla M. Natali, PharmD, BCIDP, AAHIVP. 1,. , James Fallon. 2. , Dante Puntiel. 3. , Marina Metrus. 3. , . Ammer. Al-Dairi. . Disoproxil. . Fumarate. (TDF)-Based Regimen to a . Tenofovir. . Alafenamide. (TAF)-Based Regimen: Data in . Virologically. Suppressed Adults Through 48 Weeks of Treatment. Anthony Mills,. 1. .